Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*
By J. Garnacho-Montero, J. García-Garmendia, A. Barrero-Almodóvar, F. Jiménez-Jiménez, C. Pérez-Paredes, C. Ortíz-Leyba. Critical Care Medicine, 2003
733 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Epidemiology
View Paper: https://www.semanticscholar.org/paper/cc3d8c3ef517d8b40328f2de8da9c234581e585a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Critical Care and Intensive Care Medicine
In Epidemiology
Citations in the corpus
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria (2012, background): “The use of at least one antimicrobial agent to which a pathogen is susceptible for empiric therapy leads to lower mortality and improved outcomes in patients with sepsis caused by Gram-negative bacteria, as observed in a number of studies (6, 33, 46, 48, 84, 89, 106, 108, 133, 137, 140, 153, 158, 17”
- Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. (2008, neutral): “5) [4-7] 86 (5.”
- Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality (2005, background): “More recently, the same finding has been demonstrated for patients with severe sepsis ( 8 , 10).”
- Pharmacokinetic issues for antibiotics in the critically ill patient (2009, background): “Developing dosing regimens that maximize the rate of response in ICU patients is important for optimizing patient outcomes and minimizing the development of antibiotic resistance (2, 3, 5, 9).”